HR 3250 · 114th Congress · Health
DXM Abuse Prevention Act of 2015
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Placed on the Union Calendar, Calendar No. 520.(2016-07-08)
Plain Language Summary
[AI summary unavailable — showing source text]
DXM Abuse Prevention Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed. To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 3250, DXM Abuse Prevention Act of 2015
Jun 28, 2016As ordered reported by the House Committee on Energy and Commerce on April 27, 2016
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (20)
10 Democrats10 Republicans